Reacción #95618

ord-508170efaffd47d9aff5fccabb46428b

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Temperaturato reflux
  2. 2
    workup.ADDITIONThe mixture is treated with a 0.5 g portion of Sicapent after 16 hours, 19 hours and 24 hours
  3. 3
    TemperaturaThe mixture is subsequently cooled
  4. 4
    OtroAfter separation of the organic phase
  5. 5
    Extracciónthe alkaline-aqueous phase is extracted twice with 250 ml of ethyl acetate each time
  6. 6
    LavadoThe organic extracts are washed twice with saturated sodium chloride solution
  7. 7
    Otrodried
  8. 8
    Otroevaporated
  9. 9
    OtroAfter crystallisation of the residue from methylene chloride/hexane, there
  10. 10
    Otrois recovered a portion
  11. 11
    OtroThe mother liquor is evaporated
  12. 12
    Otrochromatographed on 100 g of silica gel
  13. 13
    Lavadowhile eluting with ethyl acetate and alcohol
  14. 14
    OtroAfter recrystallisation of the thus-obtained substance from acetone

Procedimiento

0.5 g of 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxamide is heated to reflux while stirring for 40 hours together with 0.5 g of Sicapent in 150 ml of toluene. The mixture is treated with a 0.5 g portion of Sicapent after 16 hours, 19 hours and 24 hours. The mixture is subsequently cooled and treated with water. The mixture is adjusted to pH 9 with 28 percent sodium hydroxide. After separation of the organic phase, the alkaline-aqueous phase is extracted twice with 250 ml of ethyl acetate each time. The organic extracts are washed twice with saturated sodium chloride solution, dried and evaporated. After crystallisation of the residue from methylene chloride/hexane, there is recovered a portion of unreacted starting material. The mother liquor is evaporated and chromatographed on 100 g of silica gel while eluting with ethyl acetate and alcohol. After recrystallisation of the thus-obtained substance from acetone, there is obtained 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[ 1,5-a][1,4]benzodiazepine-3-carbonitrile of melting point 184°-185° C.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US04346030uspto-grants-1982_08